Analyst Ratings for Cytokinetics (CYTK) [Buys]
CYTK Rating Summary
CYTK Price Target Summary
- Highest: $122.00 (B.Riley)
- Lowest: $48.00 (JPMorgan)
- Average: $79.77
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$79.77 (+21.3%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Avg. $ Target:
$79.77 (+21.3%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/9/2023 | Goldman Sachs » Updated 12/28/2023 |
Paul Choi | New Coverage | Buy (N/A) |
85.00 (50.00) |
35.85 (65.78) |
83.49% | Details |
| 11/7/2023 | B.Riley » Updated 1/8/2024 |
Mayank Mamtani | New Coverage | Buy (N/A) |
122.00 (66.00) |
36.32 (65.78) |
81.11% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
